Project Details
Projekt Print View

Pathomechanisms of native tear protein complexes in dry eye syndrome

Subject Area Ophthalmology
Biochemistry
Term from 2021 to 2025
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 452535756
 
Final Report Year 2025

Final Report Abstract

This project characterized the native tear proteome and elucidated the intricate regulation of signaling pathways underlying the pathomechanistic changes in dry eye syndrome (DES) patients. We provided the first experimental evidence of the complex interplay of eight novel supramolecular protein complexes in human tears, including the first report of a megadaltonscale complex (CI, 1050 kDa). Notably, CI-associated proteins were significantly lower in abundance in the combined evaporative and aqueous-deficient DES (DRYaqlip) compared to the healthy (CTRL) and reflex groups, demonstrating a disruption in tear film homeostasis. These are predominantly lacrimal-specific proteins (e.g., IGHA1, PRR4, LACRT, PROL1, PIGR), which were significantly enriched in antibacterial response, dry eye, and tear secretion. Conversely, a cluster of significantly high abundant proteins in DRYaqlip vs. CTRL were associated with <250 kDa complexes (CIV–CVIII), which exhibited intricate interactions and enriched functions in inflammation, metabolism, oxidative stress, and cytoskeletal organization. We also analyzed the largest tear sample cohort to date (N=322) employing the clinical proteomics strategy to analyze inter-individual proteome alterations and their correlations to various clinical attributes i.e. age, basic secretory test (BST), tear break-up time, ocular surface disease index, visual analog scale and body mass index. A key finding was the identification of 36 proteins (e.g. LTF, LYZ, LCN1, LACRT, PROL1, PRR4, ZG16B), which were correlated negatively with age and positively with BST, suggesting an agerelated decline in tear production and antimicrobial defense. Conversely, 307 proteins annotated to cytoskeletal organization, apoptosis, inflammation, autophagy, and protein metabolism showed the opposite trend. The trends in BST and age aligned with CI impairment, characterized by decreased secretory proteins and elevated CIV–CVIII complexes. Finally, we identified two PRR4 peptide isoforms, a potential marker for CI, as promising therapeutic candidates with protective effects in a human corneal epithelial cell culture DES model. These PRR4 isoforms demonstrated significant anti-inflammatory, antiapoptotic, and anti-oxidative stress properties, providing a foundation for synthetic peptidebased eye drops as a potential therapeutic strategy to restore ocular surface homeostasis in DES. In summary, this study provided a comprehensive insight into the functional roles of the native tear proteome in maintaining tear film homeostasis and identified clinical markers with significant correlation with specific clinical attributes. These findings bridge the native molecular discoveries with clinical insights, laying the foundation for improved diagnosis and prognosis of DES. Notably, PRR4-derived peptides introduce a first-of-its-kind therapeutic strategy, paving the way for innovative treatment options to improve DES patient outcomes and quality of life.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung